VTVT Earnings

Quarterly EPS
$-0.88
Q3 2024
$-0.51
Q4 2024
$-0.77
Q1 2025
$-0.92
Q2 2025
$-1.08
Q3 2025
$-0.57
Q4 2025
$1.94
Q1 2026
$-1.05
Q2 2026
Latest RevenueN/A
Latest Net Income-13054000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.050-13054000-14.1%
Q1 2026$1.9436.8M24.1M+351.9%
Q4 2025-$0.570-7138000-100.0%-11.8%
Q3 2025-$1.080-10345000-22.7%
Q2 2025-$0.920-7380000-13.6%
Q1 2025-$0.770-6217000-100.0%+34.2%
Q4 2024-$0.5117.0K-4437000+69.5%
Q3 2024-$0.880-5840000+72.4%
Q2 2024-$0.810-6409000
Q1 2024-$1.171.0M-6019000
Q4 2023-$1.670-4441000
Q3 2023-$3.190-8540000
vTv Therapeutics (VTVT) — Earnings